DuPont de Nemours, Inc. DD benefits from its innovation-driven investment, productivity actions and the acquisitions of the Spectrum Plastics Group and Donatelle Plastics amid uneven construction demand and persistent cost pressure.
DuPont, which is among the prominent players in the chemical space along with Dow Inc. DOW, Air Products and Chemicals, Inc. APD and Eastman Chemical Company EMN, remains focused on organic growth through innovation, commercial execution and targeted acquisitions. Its innovation-driven investment is focused on several high-growth areas. DD's portfolio is exposed to healthcare, water, aerospace and electric vehicle (EV) applications, which supported 4% organic sales growth in second-quarter 2026. The company is expanding its innovation pipeline through direct lithium extraction solutions in Water, Liveo products for biopharma and new solutions for electric vehicles and battery energy storage.
The acquisition of Spectrum Plastics Group, a leading manufacturer of specialty medical devices and components, strengthened DuPont’s position in stable and fast-growing healthcare end markets. It is also in sync with its focus on high-growth, customer-driven innovation for the healthcare market. The buyout of Donatelle Plastics also enhances DD’s exposure in healthcare, expanding its expertise in the medical device market segments.
DD said in August 2026 that it still had more than $1 billion available for potential mergers and acquisitions and was evaluating opportunities in water and healthcare. It also indicated that prospective acquisitions should add to the company’s growth algorithm and meet disciplined return thresholds. These actions support a more focused portfolio while retaining flexibility for selective growth investments and shareholder returns.
DuPont is also benefiting from cost synergy savings and productivity improvement actions. Its operating system is producing measurable cost and execution gains. In second-quarter 2026, net productivity improved and contributed to operating leverage. Management is targeting net productivity equal to 3% of cost of goods sold and expects to reach that run rate within about 18 months from August 2026. The 80/20 program is also moving from pilot work to implementation across four Diversified Industrials businesses, with a few million dollars of EBITDA benefit expected in second-half 2026.
Following its second-quarter outperformance, DuPont raised the midpoint of its full-year 2026 operating EBITDA and adjusted earnings guidance. The company now expects net sales in the range of $7.16-$7.19 billion, operating EBITDA between $1.75 billion and $1.77 billion and adjusted earnings of $7.17-$7.32 per share.
Another prominent chemical maker, Dow expects approximately $200 million in additional benefits from Transform to Outperform during 2026. This raises the company’s expected total in-year benefits from self-help initiatives to more than $1.3 billion. For the second half of 2026, DOW plans to focus on growth and innovation in attractive end markets, investments to strengthen the portfolio and balanced capital allocation. DOW expects the growth and productivity benefits from Transform to Outperform to accelerate through the remainder of 2026 and into 2027.
Air Products, on its fiscal third quarter call, raised its fiscal 2026 adjusted earnings guidance to $13.39-$13.49 per share from the prior range of $13.00-$13.25. For the fourth quarter of fiscal 2026, APD expects adjusted earnings of $3.55-$3.65 per share.
Eastman Chemical, on its second-quarter call, said that it expects 2026 earnings to improve significantly from 2025. EMN remains on track to deliver cost reductions of $125 million to $150 million, net of inflation, and continues to project capital expenditures of approximately $400 million. Operating cash flow is now expected to approach $900 million, modestly below the prior expectation of approaching the 2025 level.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
Air Products and Chemicals, Inc. (APD): Free Stock Analysis Report
Dow Inc. (DOW): Free Stock Analysis Report
Eastman Chemical Company (EMN): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).